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Abstract
Background: The Molecular Interaction Map (MIM) notation offers a standard set of symbols and rules on their
usage for the depiction of cellular signaling network diagrams. Such diagrams are essential for disseminating
biological information in a concise manner. A lack of software tools for the notation restricts wider usage of the
notation. Development of software is facilitated by a more detailed specification regarding software requirements
than has previously existed for the MIM notation.
Results: A formal implementation of the MIM notation was developed based on a core set of previously defined
glyphs. This implementation provides a detailed specification of the properties of the elements of the MIM
notation. Building upon this specification, a machine-readable format is provided as a standardized mechanism for
the storage and exchange of MIM diagrams. This new format is accompanied by a Java-based application
programming interface to help software developers to integrate MIM support into software projects. A validation
mechanism is also provided to determine whether MIM datasets are in accordance with syntax rules provided by
the new specification.
Conclusions: The work presented here provides key foundational components to promote software development
for the MIM notation. These components will speed up the development of interoperable tools supporting the
MIM notation and will aid in the translation of data stored in MIM diagrams to other standardized formats. Several
projects utilizing this implementation of the notation are outlined herein. The MIM specification is available as an
additional file to this publication. Source code, libraries, documentation, and examples are available at http://
discover.nci.nih.gov/mim.
Background
Diagrams have long been used to organize knowledge,
and there has been an ever-growing use of such dia-
grams in biological sciences in the last half century. As
their use increases so does the need for common meth-
ods to communicate biological knowledge accurately
from author to reader in a manner similar to other dis-
ciplines that use technical drawings. Advances in mole-
cular biology experimental techniques have resulted in
an abundance of high-throughput data, placing addi-
tional emphasis on the need for the organization and
visualization of biological data. Since its inception in
1999, the Molecular Interaction Map (MIM) notation
has helped address this need for standardized represen-
tation of biochemical and cellular processes through a
notation that shares visual characteristics with electrical
circuit diagrams [1]. The notation has been featured in a
variety of publications as the mechanism used to orga-
nize biological information and the basis for mathemati-
cal simulations [2-14]. The MIM notation has also
garnered wide attention in the systems biology commu-
nity. It has been advocated as a notation for graphical
display of purely textual datasets such as those based on
the BioPAX ontology [15]. The notation has also helped
spur the creation of the Systems Biology Graphical
Notation (SBGN) consortium, which uses the MIM
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(SBGN ER) language [16,17]. Potentially, the two graphi-
cal notations may converge.
As the amount of data in MIM diagrams increases,
the availability of that data becomes a priority because
the diagrams can serve as sources of data to be mined.
The information content of MIM diagrams is often
extended with annotations containing ancillary informa-
tion, such as comments, external links, and citations;
annotations are denoted as labels on interaction lines
[1]. Annotations provide readers with additional insight
into the systems they represent, which may not be cap-
tured by the MIM glyphs per se (e.g. information
regarding time, location, and sequence of events). These
annotations have recently been mined in the work by
M c I n t o s ha n dC u r r a nw h ob u i l taM I Mc o r p u st h a t
maps MIM annotations to passages from the original
research articles [18].
The present work outlines an implementation of the
MIM notation and provides a new specification with a
series of software tools based on this specification. Pre-
sented first is the new specification that addresses pre-
vious ambiguities in the notation, provides definitions as
a foundation for translation, and establishes a set of syn-
tax rules for the validation of MIM diagrams; the speci-
fication is provided as Additional file 1. This
specification forms the basis of an XML-based format
that includes elements to capture both the graphical and
non-graphical elements of MIM diagrams. The next
topic presented is a mechanism for validating MIM
datasets according to the syntax rules found in the spe-
cification. Lastly, an application programming interface
(API) is provided as a support mechanism for develo-
pers to interact with specific features of the MIM
format.
Methods and Results
Description of the Formal MIM Specification
The MIM notation has been described previously in sev-
eral publications [1,19-21]. The formal implementation
presented below is based on the most widely used fea-
t u r e si nt h eM I Mn o t a t i o na sp r e s e n t e di n2 0 0 6[ 2 1 ] ,
and retains the goal of the MIM notation to present
unambiguous and accurate diagrams of biological sys-
tems, while simplifying the visualization of these dia-
grams. The complete MIM specification is provided as
Additional file 1 and online on our project homepage
(http://discover.nci.nih.gov/mim).
MIM Notation Elements
MIM diagrams represent bioregulatory networks invol-
ving graphical elements broadly divided into two cate-
gories: entity and interaction glyphs. Entities may
represent objects in nature with physical structures,
such as biological molecules (e.g. protein, DNA, RNA,
etc), or non-physical objects, such as phenotypes, beha-
viors, perturbations, cell cycle states, etc. Interactions
are relationships between an entity and other entities or
interactions. Interactions between two entities are repre-
sented in the form of binding interactions (e.g. the bind-
ing of calcium to calmodulin) or the transformation of
one entity into another (e.g. the ADP and phosphate to
ATP). An interaction between an entity and another
interaction can be used to describe the influence the
entity exerts on the interactions, such as the inhibition
of binding between two proteins by a third. The basic
graphical elements that represent MIM elements are
referred to as glyphs and are shown in Figure 1 and full
details on their usage are provided in Additional file 1.
Entity glyphs are differentiated by their shapes, and
the various types of interactions are represented by lines
with different arrowheads or other line end-marks. For
some glyphs, the semantics of the glyph are determined
by the context in which the glyph is used; examples of
these cases include the production without loss and sti-
mulation glyphs. The simple physical entity and entity
feature glyphs, and restricted copy entity glyphs shown
in Figure 1, while explicit and implicit complex forma-
tion are shown in Figure 2. As has been the case with
previous MIM specifications, the color of a glyph does
not affect its semantics. The accompanying MIM speci-
fication describes the full set of MIM glyphs shown in
Figures 1 and 2 along with their appropriate use.
Entity Glyphs
The MIM notation supports various types of entities,
each represented by a different glyph. The most com-
mon entity glyph is a labeled rounded-rectangle that
represents a simple physical entity (SPEs) where “sim-
ple” denotes that the entity is not in a complex with
other entities; this glyph is used to represent molecules
such as proteins, DNA, RNA, etc. The labels of SPEs are
the main identifiers used by readers in understanding
MIM diagrams, and it would be helpful for the purpose
of data exchange that standardized nomenclatures, such
as HGNC names for genes, be used.
An SPE can also be represented in a manner that
defines specific regions of molecules, such as protein
domains, motifs, and sites. This representation provides
a more detailed description of an SPE through the use
of entity features. Entity features can be used to indicate
specific regions of an SPE that carry out a particular
function as illustrated in Figure 2.
SPEs are typically represented only once in a given
diagram, which allows for the traceability of all the
interactions of a given entity to a single location on a
diagram. Modifiers are physical entities that are repre-
sented as labels without borders and generally represent
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Page 2 of 13small molecules (e.g. phosphate, methyl, or ubiquitin
molecules) that can be depicted multiple times in a dia-
gram. Such small molecules tend to exist frequently in
pathway interactions, and it would be prohibitive to
route all the connections of a small molecule to a single
glyph.
SPEs can exist in complexes with other entities. There
are two types of complexes in MIM: explicit and impli-
cit complexes as shown in Figure 2. Explicit complexes
are diagrammed as small filled circles on binding inter-
action lines, and are termed “explicit” because the bind-
ing partners that give rise to them are shown. Implicit
complexes, however, are diag r a m m e da se n c l o s u r e so f
SPEs and indicate an implied relationship between the
SPEs without showing their direct interactions. Figure 3
shows a complex of SPEs A, B, and C as an explicit
complex. The interaction between A and B forms the
complex A:B, which is then bound to C. As represented
as an explicit complex, A and B cannot be unbound if C
is bound to the A:B complex; this represents a common
mechanism whereby C stabilizes the A:B interaction.
The notation implies that SPEs A and B must bind to
each other before C can bind to them. If A and B
unbind, then there would no longer be an A:B for C to
bind to. Therefore, SPE C must dissociate first before A
and B can dissociate. The implicit complex SPEs shown
in Figure 2 does not provide readers of the MIM dia-
gram with information on the binding order of entities
unlike the explicit complex representation. This repre-
sentation is useful when binding order is unknown or
when those details are not relevant to the intent of the
diagram.
Entity Glyphs
Conceptual entity
Simple physical
 entity
LABEL
LABEL
ø Source/Sink
LABEL:POSITION Modifier
Restricted copy
Reaction Glyphs
Non-covalent reversible binding 
Covalent modification
Stochiometric conversion
Production without loss
Template reaction
Covalent irreversible binding
Contingency Glyphs
Stimulation
Necessary
stimulation
Inhibition
Catalysis
Catalytic Interaction Glyphs
Covalent bond 
cleavage
Absolute
Inhibition
Entity feature LABEL
Figure 1 Basic glyphs used in this implementation of the MIM notation. The MIM notation consists essentially of glyphs representing
entities and interactions; shown are the independent glyphs. A description of the usage for all the glyphs in the MIM notation is provided in
Additional file 1.
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Page 3 of 13Since SPEs tend to appear once on a diagram, it
becomes necessary to have a method for diagramming
homo-dimerization interactions. Such interactions make
use of restricted copy entities, small black dots that act
as copies of the SPEs to which they are bound.
Restricted copy entities cannot be included in any other
interaction; the complexes resulting from homo-
dimerization interactions can participate in interactions
in the same way as other explicit complexes.
There are two additional MIM entity glyphs: concep-
tual entity and source/sink glyphs. Conceptual entities,
shown by a rectangular glyph, can be used to represent
objects that do not have a clear physical structure (e.g.
ionizing radiation) or whose physical structure is outside
the scope of the given diagram. The source/sink symbol
uses the mathematical symbol for an empty set and can
be used to represent an unlimited and unspecified
source for the production of an entity or an unspecified
product of a degradation reaction.
Interaction Glyphs
The notation has three categories of interactions that
exist between entities: reactions (i.e. an interaction
where the input and output are both entities), catalytic
interactions (i.e. an abbreviation for a known set of reac-
tions), and contingencies (i.e. an interaction in which a
A
Dimer formation 
using restricted copy
Additional Representations
Simple Physical Entity Features Branching
Branching glyph
Intermolecular interaction
Label Feature 1 Start:Feature 2:End
State combination
Complex Formation 
Implicit complex
A B
Explicit complex
    A 
    B
    C
Figure 2 More advanced use cases of MIM glyphs. Examples of cases involving multiple MIM glyphs to represent a concept.
Figure 3 Example of a trimer between simple physical entities
A, B, and C. The explicit complex node on the binding interaction
line between entities A and B denotes the dimer A:B and the
binding interaction between this complex and C denotes the trimer
A:B:C.
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Page 4 of 13controller entity regulates, modifies, or otherwise influ-
ences another reaction or contingency); all the interac-
tion glyphs are shown in Figure 1. For brevity, only the
usage of a limited number of interactions is presented
here. Readers are directed to the MIM specification for
a description of all interaction types. The reaction types
include non-covalent reversible binding, covalent modi-
fication, covalent irreversible binding, template reaction,
stoichiometric conversion, and production without loss
of reactants.
Non-covalent reversible binding is represented as a
double-headed line with barbed arrowhead endings con-
necting two entities; barbed arrowheads are permissible
only in accordance with the specification rules outlined
in Table three of the MIM specification. The outcome of
an interaction represented by a non-covalent reversible
binding glyph is an explicit complex, indicated by a filled
circle on the interaction line; the resulting explicit com-
plex can then participate in additional valid interactions.
Covalent irreversible binding functions in the same
manner as non-covalent reversible binding, but with dif-
ferent semantics, namely that those interactions must be
covalent and not directly reversible. Covalent modifica-
tion uses a single-headed line with a barbed ending
pointing towards the modified entity with a modifier
entity on the end of the line that is not barbed, as
shown in Figure 4.
Stoichiometric conversion uses a single-headed line
with a triangle end that points from the reactant to the
product. The stoichiometric conversion can be used to
describe the production of multiple entities, as shown in
Figure 5.
The MIM notation also offers glyphs to describe the
stimulation and inhibition of other interactions, and
these are part of the set of contingency interactions. An
unfilled triangle arrowhead is used to represent stimula-
tion, while a terminal bar is used for inhibition. To indi-
cate that an entity is necessary for a process to occur, a
bar is placed behind the unfilled triangle of the stimula-
tion glyph.
Catalytic interactions follow a similar set of syntactic
rules as contingencies, but represent interactions requir-
ing a catalyst (e.g. the enzymatic activity of a kinase or
phosphatase).
The MIM specification provides additional examples
and guidance on the usage of the glyphs in the notation,
especially in more complicated situations.
Formal Rules for MIM
One of the key features of this new implementation of
the MIM notation is the introduction of a strict set of
syntax rules that provide constraints on valid MIM dia-
grams. Previous MIM publications presented both basic
and elaborate examples, but did not codify the extent of
the syntactic capabilities of the elements of the notation.
There was no clear method to validate diagrams in
terms of the manner in which elements are connected.
The new syntax rules presented here will help users cre-
ate and update valid MIM diagrams.
The syntax rules presented in Table three and Table
four in Section 8.1 of the MIM specification treat each
interaction glyph as having three possible places of con-
nection: the start, the end, and the line itself. For sym-
metric interactions (e.g. non-covalent reversible binding
and covalent irreversible binding), either terminus of the
line may be considered the start of the interaction with
respect to the syntax rules. For all other interactions
types, the line terminus without an arrowhead is consid-
ered the start of the interaction. The syntax rules outline
what entities may connect to the start and end of an
interaction line and whether a symbol can exist on an
interaction line between its termini. Additional rules in
the formal MIM specification outline the usage of
branching glyphs, as well as other syntactic rules.
In addition to these rules, the MIM specification out-
lines how glyphs should be interpreted in conjunction
with other glyphs. Section 8.4 of the MIM specification
specifically outlines correct interpretations of the pre-
sence of entities given the potential incompleteness of
knowledge about a particular entity based on the inter-
actions in a diagram. This is closely aligned to the ideas
of the “heuristic” MIM interpretation, which recognizes
t h a tt h er o l eo f“transitive” effects (the effect of a given
interaction on others) is often unknown [21,22].
Limitations of the Formal Implementation
The MIM notation formalized by the current specifica-
tion is constrained to facilitate the implementation of
software tools for MIM, and does not include all MIM
glyphs that have been published previously. In the nota-
tion’s history there have been variations in the represen-
tation of certain glyphs; this issue has been addressed by
choosing a single representation for each concept in the
notation. This implementation of the notation does not
Figure 4 Formation of the phosphorylated entity A.E x p l i c i t
complexes placed on the covalent modification lines represent the
modified entity.
Figure 5 Conversion of one entity into multiple entities.T h e
stoichiometric conversion of entity A to entities B and C.
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Page 5 of 13permit ad hoc glyph creation. This facilitates the valida-
tion of diagrams and allows software developers to be
confident that they have implemented all known fea-
tures of the implementation; other glyphs may be added
in future releases of the specification.
As the notation has evolved, several shorthand nota-
tion elements have been developed to simplify common
patterns in MIM diagrams. The current implementation
includes only some of these shorthand notation ele-
ments from previous MIM publications. Undoubtedly,
this means that certain constructs in diagrams will be
more visually complex, but since these elements do not
add to the semantic capacity, they have been postponed
for future releases.
The specification presented here does not provide
strict guidance on the glyphs of the notation that are
suitable for computational simulations; this topic has
been discussed previously regarding the manner in
which the MIM notation may be used in conjunction
with mathematical simulations [2,21]. One future devel-
opment that may support such a goal is by outlining an
additional validation method for glyphs appropriate in
computational simulations.
Lastly, this implementation does not specify a notation
to represent transport interactions. Entities in the MIM
notation may represent a given entity in multiple states
(e.g. a protein with some molecules in the nucleus and
others in cytoplasm). With no clear way of distinguish-
ing these states, the semantics of a transport interaction
would be unclear; this is a problem common to other
similar notations such as the SBGN ER Level 1 Version
1.2 notation [16]. In previous MIM publications, trans-
port reactions have been represented by a stoichiometric
conversion glyph. In many cases this representation is
clear and unambiguous. That representation, however,
sometimes introduces awkward ambiguities. Therefore,
we did not include transport reactions in the current
version of the formal MIM specifications.
Limitations of Current Machine-Readable Representations
of MIM Diagrams
Several software projects have included support for the
notation and have each addressed the lack of a standar-
dized data model for the MIM notation differently. The
first associated software project for MIM diagrams inte-
grated the diagrams with metadata in the form of E-
MIMs (electronic MIMs) found at http://discover.nci.
nih.gov/mim[21]. E-MIMs store the diagrams using the
SVG (Scalable Vector Graphics) format to provide inter-
active features allowing the graphic elements to be con-
nected to metadata. The SVG format does not retain
the semantics of the elements visualized, and the meta-
data, currently, are reintroduced to the SVG files
through a post-processing step.
Another project, the Java-based biological pathway
diagram editor PathVisio, has included the glyphs of the
notation for the purpose of facilitating the production of
MIM diagrams [23]. The PathVisio software provides
MIM-specific interaction glyphs for diagrams that are
stored using the GPML (GenMAPP Pathway Markup
Language) format. The MIM-specific glyphs were pro-
vided as additions to the pre-existing PathVisio glyphs
that are external to the MIM notation. If users include
both MIM-specific and external glyphs, a diagram will
be viable in the context of the GPML format, but will
lose the consistency required for exchange with other
MIM-specific tools and tasks, such as validation.
Software support for MIM was recently provided by
the MIMCITY database project (http://www.mimcity.
org) for storing, querying, visualizing and analyzing data
contained in MIM diagrams [Karac, et al., in prepara-
tion]. The project developed an accompanying data
model implemented in the form of a database schema
that is compatible with an SBML-based representation
of the MIM notation also developed for that project.
The SBML-based MIM representation addresses incom-
patibilities between the MIM and SBML through the
use of SBML annotation containers to embed MIM
information content not supported in SBML. The MIM-
CITY database schema and the SBML-based MIM
representation, however, do not include elements to
describe the visualization of MIM diagrams.
Overview of MIM Schema
The various formats used in the aforementioned projects
have limitations that highlight the need for a standard
format to support future MIM software projects. The
new MIM Markup Language (MIMML) meets this need
and provides a standard format for the exchange of MIM
diagrams among different software. The MIMML format
conforms to XML Schema 1.0, and is based on the
GPML schema developed for use with PathVisio [23,24].
MIM datasets are plain-text XML data streams: the data-
sets are characterized by matching start and end tags,
and elements can contain attribute-value pairings. The
schema is used to store information about the visual pre-
sentation (e.g. positioning, color, or size) and layout of
the diagram as well as accompanying metadata (relation-
ships to external databases, annotations, and citations).
The MIMML format employs several XML elements
of different types; the ones of most importance are out-
lined here. The root element of the MIMML schema is
the Diagram XML element used primarily to store size
information about the diagram. This element can have
several types of child elements; primarily these include:
EntityGlyph, InteractionGlyph, Anchor and MimBio
XML elements; Figure 6 shows a small MIMML dataset
that includes examples of all the MIMML elements
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Page 6 of 13described; other example files on the website have more
comprehensive examples (http://discover.nci.nih.gov/
mim). EntityGlyph is used to store information about all
MIM entities. This is a departure from GPML, which
stores information in implicit and explicit complexes as
groups and anchors, respectively. This change allows for
a uniform mechanism when validating MIM entity
glyphs. InteractionGlyphs are used to store information
about interactions and the elements to which they are
connected. An InteractionGlyph XML element is made
<?xml version="1.0" encoding="UTF-8"?>
<mimVis:Diagram width="158.4" height="146.3" xmlns:mimVis="http://lmp.nci.nih.gov/mim/mimVisLevel1">
    <mimVis:EntityGlyph visId="a6fc4" centerX="47.0" centerY="123.0" width="60.0" height="20.0" 
  color="000000" type="SimplePhysicalEntity" displayName="CaMK">
    </mimVis:EntityGlyph>
    <mimVis:EntityGlyph visId="e839e" centerX="47.0" centerY="38.0" width="20.0" height="20.0" 
  color="000000" type="Modifier" displayName="P">
    </mimVis:EntityGlyph>
    <mimVis:EntityGlyph visId="a677d" centerX="114.0" centerY="74.0" width="60.0" height="20.0" 
  color="000000" type="SimplePhysicalEntity" displayName="Phtase">
    </mimVis:EntityGlyph>
    <mimVis:InteractionGlyph visId="id4f7e9fd7" color="000000">
        <mimVis:Point x="47.0" y="48.0" arrowHead="Line" visRef="e839e" relX="0.0" relY="1.0"/>
        <mimVis:Point x="47.0" y="113.0" arrowHead="CovalentModification" visRef="a6fc4" relX="0.0" relY="-1.0"/>
        <mimVis:anchorRef>bd4fd</mimVis:anchorRef>
        <mimVis:mimBioRef>b8e</mimVis:mimBioRef>
    </mimVis:InteractionGlyph>
    <mimVis:InteractionGlyph visId="id82185491" color="000000">
        <mimVis:Point x="47.0" y="74.0" arrowHead="CovalentBondCleavage" visRef="bd4fd" relX="0.0" relY="0.0"/>
        <mimVis:Point x="84.0" y="74.0" arrowHead="Line" visRef="a677d" relX="-1.0" relY="0.0"/>
    </mimVis:InteractionGlyph>
    <mimVis:Anchor visId="bd4fd" position="0.4" type="Invisible"/>
    <mimVis:MimBio>
        <mimVis:title>CaMK Phosphorylation</mimVis:title>
        <mimVis:identifier>20101117</mimVis:identifier>
        <mimVis:PublicationXRef visId="b8e">
            <mimVis:db>PubMed</mimVis:db>
            <mimVis:id>16267266</mimVis:id>
            <mimVis:title>Molecular interaction maps of bioregulatory networks: 
    a general rubric for systems biology.</mimVis:title>
            <mimVis:author>Kohn KW</mimVis:author>
            <mimVis:author>Aladjem MI</mimVis:author>
            <mimVis:author>Weinstein JN</mimVis:author>
            <mimVis:author>Pommier Y</mimVis:author>
            <mimVis:year>2006</mimVis:year>
            <mimVis:journal>Mol Biol Cell</mimVis:journal>
        </mimVis:PublicationXRef>
    </mimVis:MimBio>
</mimVis:Diagram>
Figure 6 Example MIMML dataset that describes the interaction of the cleavage of phosphate from CaMK. Blue: Highlighted section
describes graphical elements of the MIM notation. Red: Highlighted section describes metadata components of the MIM notation including
diagram title and identifier and a publication cross-reference.
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Page 7 of 13up of several Point elements. Point elements provide
routing information and store type of arrowheads used
in a given interaction as shown in Figure 6. For the pur-
poses of validation, the MIMML schema, unlike GPML,
restricts the types of arrowheads that can be used to
only those that exist in the MIM notation. The first and
last Points of an InteractionGlyph contain the visRef
attribute to specify to which MIM element each line
end is connected; shown in Figure 6. InteractionGlyphs
may also include attributes pointing to Anchor XML
elements. Anchors are connection points on an Interac-
tionGlyph. These are used to connect interactions to
each other, as is the case with contingencies, and also,
to represent the intramolecular glyph on an interaction.
The XML elements for interactions and entities can
also include references to particular metadata items
stored in the MIMBio XML element that acts as the pri-
mary location for the storage of MIM metadata. The
MIMML format supports two types of metadata: cross-
references and annotations. Cross-references allow the
mapping of external database resources to MIM ele-
ments. Annotations exist as two components: a com-
ment and a publication cross-reference. This allows
users to map particular interactions to the publications
that provide evidence for the existence of the interac-
tion, while the comments stored for specific MIM ele-
ments provide additional information about entities and
interactions not captured by the notation. The structure
of MIM cross-references is modeled after those in the
BioPAX format [25]. The MimBio XML element also
stores metadata related to the diagram, such as title and
creator information; these elements are similar to those
provided in GPML with the exception that they use
terms from the Dublin Core set of metadata terms
(http://dublincore.org/).
The MIMML schema adds metadata elements to allow
controlled vocabulary to be used to describe the
relationship of an external database resource and a MIM
element and to allow users to specify the biological prop-
erties of entities through controlled vocabulary beyond
the generic terminology used by the MIM notation (e.g. a
simple physical entity can be described as a protein,
DNA, RNA, etc). The values for element type were
adopted from the BioPAX format to simplify the process
of translating MIM diagrams to BioPAX datasets.
An Example Diagram and MIMML Dataset
In this section, we provide an example of the MIM
notation and MIMML format with the use of the Ca2
+/calmodulin-dependent protein kinase (CaMK) MIM
diagram (shown in Figure 7) stored in the MIMML for-
mat and provided as supplemental information. The
CaMK regulation MIM was originally introduced in the
2006 specification of the MIM notation as Figure twelve
of that publication; a full description of the interactions
is included by Kohn et al [21]. The diagram covers
many of the properties of the MIM notation, thereby
making it useful when describing the changes that have
been made to the MIM notation. The CaMK example
shows the intramolecular control of the protein kinase
CaMK, and how this regulation can affect the phosphor-
ylation of substrates (labeled here as “Substrates”) by the
kinase domain of CaMK. Figure 7 shows the diagram
according to the formal MIM presented here. The most
significant visual change is in the CaMK protein glyph.
The entity glyph for the CaMK protein is linked to its
two domains (the kinase and regulation domains), and
the domains have been separated so they exist in two
separate entity feature glyphs. The cleavage and intra-
molecular glyphs have undergone cosmetic changes, as
well as the way that branched interactions are sup-
ported. Changes to the diagram are largely cosmetic to
simplify the implementation of the notation in software
editors of MIM diagrams.
Figure 7 CaMK MIM diagram based on the specification outlined in the current publication.
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Page 8 of 13Validation of MIM Datasets
Datasets for each schema are validated at two levels: the
first is with regard to the well-formedness of the dataset
according the MIMML XML schema and the second
are rules that are outlined in the formal MIM specifica-
tion. The MIMML XML schema outlines the valid
structure of a MIMML dataset, which can be used for
validation purposes. The second level of rules checks
proper usage of several properties of MIMML datasets:
use of entity/interaction attributes, formats of labels for
modifiers and entity features, use of interaction arrow-
heads, placement of explicit complex and intramolecular
symbols, and connection of interactions to entities or
other interactions. Validation of MIMML datasets
against the formal MIM connection rules is done using
Schematron, a rule-based validation language for finding
patterns in XML trees [26]. Assertions about the pre-
sence or absence of these patterns can be used to deter-
mine that a document adheres to a given rule set.
Currently, MIMML datasets are not being validated
against the layout rules and recommendations found in
the formal MIM specification; the focus here is to vali-
date the syntax of MIM diagrams.
Figure 8 illustrates a rule for a MIMML dataset that
determines whether explicit complexes in a given MIM
diagram were placed on the correct types of interactions;
these interaction types include: covalent modification,
non-covalent reversible binding, covalent irreversible
binding, and state combinations. Results from validation
are returned in the Schematron Validation Report Lan-
guage (SVRL), a simple report XML-based language
(http://www.schematron.com/validators.html). The
results provide the name of the rule fired, the elements
tested, the rule tested, the location of elements failing the
test using an XPath expression, and diagnostic informa-
tion relevant to invalid elements.
The MIM Schematron rule set can be used wherever
Extensible Stylesheet Language Transformations (XSLT)
may be used with other standard XML tools. To sim-
plify the use of the Schematron rule set, it is made avail-
able in conjunction with Java-based Schematron Ant
Task (http://code.google.com/p/schematron/) along with
a Java build file to show how Schematron may be used
as a part of a pipeline and for the batch validation of
multiple MIMML datasets.
MIM Application Programming Interface (API)
Implementation
Usage of an XML-based format to store the data of MIM
diagrams allows developers to provide MIMML-related
functionality using commonly available libraries capable of
parsing XML data streams, but these libraries work at a
<!-- Validate Explicit Complex Glyph Placement --> 
<iso:pattern name="check-ec-placement" id="check-ec-placement">
 <iso:rule  context="mimVis:EntityGlyph[@type='ExplicitComplex']">
  <iso:let  name="vis-id"  value="@visId"/>
  <iso:let  name="inter"  value="//mimVis:InteractionGlyph[mimVis:anchorRef=$vis-id]"/>
  <iso:assert  test="
  $inter[mimVis:Point[@arrowHead='CovalentModification']]  or 
  $inter[mimVis:Point[@arrowHead='NonCovalentReversibleBinding']]  or 
  $inter[mimVis:Point[@arrowHead='CovalentIrreversibleBinding']]  or
  $inter[mimVis:Point[@arrowHead='StateCombination']]
  "
    diagnostics="vis-id inter-vis-id inter-start-arrowhead inter-end-arrowhead">
    Explicit complexes should only be placed on the following interaction types: covalent modification, 
    non-covalent reversible binding, covalent irreversible binding, or state combination.</iso:assert>    
 </iso:rule> 
</iso:pattern>
Figure 8 A Schematron-formatted rule validating the placement of explicit complex glyph within a MIMML dataset.B l u e :T h ec o n t e x t
to which the set of rule assertions refer; in this case, entity glyphs of type “explicit complex”. Red: Assertions related to the context XML
element. In this case, an explicit complex may only exist on interactions of the following types: covalent modification, non-covalent reversible
binding, covalent irreversible binding, and state combination. Green: A set of diagnostic entries to be displayed, if the test assertion fails,
including the ID of the explicit complex glyph (vis-id), the ID of the interaction on which the explicit complex appears (inter-vis-id), and the
types of arrowheads at the start and end of the interaction glyph (inter-start-arrowhead and inter-end-arrowhead).
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MIM API provides a higher-level of functionality to inter-
act directly with features of the MIMML schema.
The MIM API is a Java-based API to the elements and
attributes for the manipulation and retrieval of informa-
tion contained in a MIM diagram set forth by the
MIMML XML schema. The interface is generated using
XMLBeans (http://xmlbeans.apache.org/) a Java-to-XML
binding framework used for developing Java applications
built around an XML schema. The framework provides
wide coverage of the features available for XML Sche-
mas and maps XML data types to Java data types.
XMLBeans generates a set of corresponding Java classes
based on an input XML Schema. These generated inter-
faces and classes can then be used by developers to
access and manipulate XML instance data using Java-
Beans-style accessors (e.g. getFoo() and setFoo()), which
are more friendly than usage the of the XML Document
Object Model (DOM). XMLbeans provides an XML
parser and validator, and it gives developers the capabil-
ity of lower-level navigation of an XML document using
XMLCursor. A complete description of XMLBeans is
available at (http://xmlbeans.apache.org/documentation/
index.html). The MIM API requires the installation of
the underlying XMLBeans library (http://xmlbeans.
apache.org). The XMLBeans library provides support for
XPath and XQuery expressions using the Saxon XSLT
and XQuery processor (http://saxon.sourceforge.net).
Usage of the MIM API
Operations using the API are aligned to the MIM XML
schema, and one Java object corresponds to each element
in the MIMML document. All of the interfaces to the
MIM elements inherit from the XMLObject interface,
provided by XMLBeans. This interface provides basic
functionality for all objects, such as the method for vali-
dation against the XML schema. Usage of the XMLBeans
library provides the capability of inputting MIMML files
in a variety of ways including from a file or string, but
the MIM API is also capable of importing from a Java
XML DOM (Document Object Model) Node object or
by retrieving a MIMML data stream using a URL (Uni-
form Resource Locator). MIMML datasets can also be
created de novo and existing datasets can be manipulated.
The MIM API supports all the constructs of the MIMML
format including the ancillary constructs, such as com-
ments, and generic properties. Using a Java-based XSLT
processing engine, such as Saxon, it is possible to addi-
tionally validate MIMML datasets against the Schema-
tron rule set within a Java program.
Benefits and Disadvantages of XMLBeans for the MIM API
The MIM API can be used in conjunction with APIs for
other formats or libraries providing other functionality,
but the major distinction between the SBML and
CellML APIs and the MIM API is the usage of an
XML-binding framework, which comes with both bene-
fits and disadvantages. One benefit is that the usage of
XMLBeans has simplified and sped up the development
of a MIM API. This has allowed the MIM API to reach
its intended audience faster, which allows developers to
concentrate on developing applications that support the
MIM notation and make use of the information content
represented by the diagrams rather through manual gen-
eration of boilerplate code. Secondly, bugs are mini-
mized due to the stability of the XMLBeans code base
resulting from over five years of development and use.
Lastly, maintainability is improved through code genera-
tion that aids in the adaption of software to future
changes made to the underlying MIM schemas. One
disadvantage in using XMLBeans is that it provides
f u n c t i o n a l i t yf o ras i n g l ep r o g r a m m i n gl a n g u a g e ,w h i c h
may be a deterrent to some developers. Both SBML and
CellML provide several language bindings [27,28]. As
the need for the support of other languages increases,
other XML-binding libraries will be used to make these
language bindings available.
Discussion and Conclusions
The Molecular Interaction Map (MIM) notation pro-
vides a way to depict bioregulatory network diagrams in
a standardized manner. The notation was originally
developed in 1999 and has since been further developed
and updated, most notably in 2006 [1,21], where a
detailed description of the glyphs and their usage was
provided. The MIM notation has been developed in a
f l u i dm a n n e rt h a th a sa l l o w e di tt od e p i c taw i d er a n g e
of biological concepts including notation for polymerase,
helicase, and primase activity as well as other symbols
[3]. These fluid advancements in the notation enhance
the range of biological networks that can be dia-
grammed, but can hamper the development of consis-
tent software for the MIM notation. Here we present a
well-defined and internally consistent MIM formalism
and set of tools that can facilitate the development of
software supporting the major parts of the MIM nota-
tion in the areas of creation, validation, and analysis of
MIM diagrams. These tools should also facilitate in
translation of MIMML-formatted diagrams to and from
other formats, such as the BioPAX or the Systems Biol-
ogy Graphical Notation Markup Language (SBGN-ML)
format currently in development (http://libsbgn.sf.net/).
SBGN-ML and other developments by the libSBGN
group will provide developers with tools similar to the
ones we present here for MIM, so that pathway editors,
such as CellDesigner, Edinburgh Pathway Editor, Path-
Visio, and VANTED, can support SBGN in a common
manner [23,29-31].
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which supports the MIMML format presented herein
(http://code.google.com/p/mimtool/) [Edes, et al., in pre-
paration]. It is limited in that it does not yet support the
metadata components of the format. MIMTool is asso-
ciated with the MIMCITY database for MIM diagrams,
which is expected to also support the MIMML format in
the future (http://www.mimcity.org) [23]. Additionally,
PathVisio (http://www.pathvisio.org) is in the process of
being extended to support the MIM specification and the
MIMML schema; one key feature being added to PathVisio
is the ability to render MIMML files (http://discover.nci.
nih.gov/mim/). The example figures associated with the
current publication have been produced in PathVisio [32].
The current work places a major emphasis in provid-
ing developers with basic tools to facilitate software
development and enhances the level of detail for the
presentation of MIM concepts. It is hoped that this new
level of detail simplifies the adoption of additional MIM
concepts into the SBGN notations or other notations.
As one example, MIMs can represent protein domains
as entity features, and this capability is important for
the depiction of many critical biological signalling path-
ways. Interactions involving domains can therefore be
represented with greater flexibility using MIMs than
with SBGN ER Level 1 Version 1.2, which currently
does not address domain representation [16]. For an
example of how SBGN addresses interactions involving
the domains represented in MIMs, the reader might
compare Figure 7 for CAMK regulation in the current
paper with Figure 2.1 in the SBGN ER specification.
While graphical notations in biology have received
strong attention in recent years, no notation has yet met
all the needs of users. One of the most recent MIM
publications [3] outlines the depiction of several new
glyphs for polymerase, helicase, and primase activity,
which helps to further the discussion on use cases still
requiring a standardized depiction.
Further developments may add new components to the
specification and the MIMML schema as the usage of
these components of the MIM notation becomes clari-
fied. Additionally, the combinatorial interpretation mode
of MIM diagrams [22] is in the process of being algorith-
mically defined and will be supported in future software.
The work presented here makes advances in the usage of
the MIM notation to visualize data in a way that is more
“natural” to humans while retaining the qualities of being
consistent and machine-readable. Participation by software
developers within our group and collaborators has helped
to ensure that all elements have a straightforward imple-
mentation. This implementation of the MIM notation will
continue to expand to cover more of the glyphs outlined in
publications on the MIM notation; each acting as a basis
for the development of MIM software support.
Availability and Ongoing Support for the MIM
Specification and Software
The schemas and API are free and open source projects
under the Apache License 2.0 that allows users to freely
copy, distribute, and modify the projects and the underly-
ing source code; this software may also be used in proprie-
tary software. All project files are stored in our SVN
repository and links to specific files, such as the MIMML
XML Schema, are provided from the project homepage.
The MIMML XML Schema is provided with documenta-
tion in the form of a webpage outlining the various XML
elements and their attributes. Sample MIMML datasets
are provided along with a Java Ant build file, which incor-
porates the Schematron Ant Task to validate the samples
according to the MIM validation rules; this provides a
mechanism to enhance the quality of MIM diagrams. This
is a stable API for the MIMML format meant for wide-
spread use. Documentation of the attributes and opera-
t i o n su s e di nt h eA P Ii sp r o v i d e du s i n gJ a v a d o c( h t t p : / /
java.sun.com/j2se/javadoc/) on the project’s SVN reposi-
tory. The projects may be updated regularly to support
new features, and contributions are welcome.
Availability and requirements
￿ Project name: MIM Specification, API and Valida-
tion Rule Set
￿ Project home page: http://discover.nci.nih.gov/mim;
SVN repository: https://ncisvn.nci.nih.gov/svn/mim
￿ Operating system(s): Platform independent. It has
been tested on Mac OS X and Windows.
￿ Programming language: Java
￿ Other requirements: Java 1.5 or higher, XMLBeans
2.4.0, ISO Schematron
￿ License: Apache License, Version 2.0
￿ Any restrictions to use by non-academics: Redistri-
bution requires compliance with the Apache License,
Version 2.0.
The project homepage provides links to project
resources (specification, source code, documentation,
and examples) of this project. Source code for the var-
ious components is available via SVN at https://ncisvn.
nci.nih.gov/svn/mim.
Additional material
Additional file 1: Formal MIM Notation Specification. Formal MIM
specification documenting MIM glyphs and their usage.
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